A 2×1 oral care strategy (2% chlorhexidine + 1% sodium bicarbonate) significantly lowers VAP rates in mechanically ventilated CKD patients.
Eine 2×1-Mundpflegestrategie (2 % Chlorhexidin + 1 % Natriumbicarbonat) senkt die VAP-Raten bei mechanisch beatmeten CKD-Patient:innen deutlich.
Anaesthesia, Pain & Intensive Care · 01.02.2026 · 29 (9) · 1184-1195
DOI: 10.35975/apic.v29i9.3052 ↗Auf einen Blick
Bei 100 beatmeten CKD-Patient:innen war 2 % Chlorhexidin plus 1 % Natriumbicarbonat mit weniger VAP verbunden als 2 % Chlorhexidin plus Kochsalzplacebo.
Fragestellung
Senkt die Kombination aus 2 % Chlorhexidin und 1 % Natriumbicarbonat im Vergleich zu 2 % Chlorhexidin allein die VAP-Inzidenz bei mechanisch beatmeten CKD-Patient:innen?
Methode
Prospektive, randomisierte, doppelblinde, placebokontrollierte Studie bei 100 CKD-Patient:innen, > 48 h beatmet; 2 Gruppen, Behandlung 2-mal täglich für 5 Tage.
Ergebnisse
VAP: 16,0 % vs. 32,0 %; P = 0,048. Späterer VAP-Beginn (Median 4,5 vs. 3,0 Tage; P = 0,032), höhere VAP-freie Überlebensrate an Tag 5 (84 % vs. 68 %).
Schlussfolgerung der Autor:innen
Bei Hochrisiko-CKD-Patient:innen auf der ICU halbierte die Zugabe von 1 % Natriumbicarbonat zu 2 % Chlorhexidin die VAP-Inzidenz, verzögerte den Beginn und verkürzte Beatmungs- und ICU-Dauer.
Kernaussagen
- VAP: 16,0 % mit Kombination vs. 32,0 % mit CHX allein
- Beatmungsdauer und ICU-Aufenthalt waren kürzer
- Die Mortalität unterschied sich nicht signifikant
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Anaesthesia, Pain & Intensive Care, online erschienen am 01.02.2026. Verfasst von Subash Sankaralingam Sankaralingam und 5 weiteren Autor:innen.
Themen: Mundpflege
Abstract (Originalsprache)
Background & objective: Chronic kidney disease (CKD) patients in the ICU have elevated ventilator-associated pneumonia (VAP) risk. Chlorhexidine (CHX) oral care is standard, but efficacy may be enhanced by adding sodium bicarbonate (NaHCO₃) to alkalinize the oral environment and inhibit pathogenic colonization. We conducted this study to determine whether combining 2% CHX with 1% NaHCO₃ reduces VAP incidence versus CHX alone in mechanically ventilated CKD patients. Methodology: In this prospective, randomized, double‑blind, placebo-controlled trial, 100 CKD patients (18–65 yrs) ventilated > 48 h were randomized to 2% CHX + 1% NaHCO₃ (n = 50) or 2% CHX + saline placebo (n = 50) twice daily for 5 days. Primary outcome: VAP incidence (CPIS ≥ 6 + clinical/radiological criteria). Secondary: oral pH, oropharyngeal colonization, microbiology, ventilation/ICU/hospital stay, mortality. Data analyzed with appropriate parametric/non‑parametric tests; P < 0.05 significant.
Results
Baseline characteristics were comparable. VAP incidence was halved with combination care (16.0% vs 32.0%; P = 0.048), with delayed onset (median 4.5 vs 3.0 days, P = 0.032) and higher Day‑5 VAP‑free survival (84% vs 68%). Oral pH rose significantly from Day 3 in the intervention arm (Day 5: 7.54 vs 7.29; P = 0.001). Heavy oral colonization was lower, but non‑significant. MDRO rates (37.5% vs 56.3%) and carbapenem resistance were reduced. Ventilation duration (6.2 ± 2.1 vs 7.8 ± 2.5 days, P = 0.004) and ICU stay (8.9 ± 3.0 vs 10.5 ± 3.4 days, P = 0.011) were shorter. However, the mortality differences were non‑significant.
Conclusions
In high‑risk CKD ICU patients, adding 1% NaHCO₃ to standard 2% CHX oral care halved VAP incidence, delayed onset, improved oral pH, reduced resistance rates, and shortened ventilation/ICU stays. This simple, low‑cost measure warrants incorporation into VAP prevention bundles. Keywords: Ventilator‑associated pneumonia, chronic kidney disease, chlorhexidine, sodium bicarbonate, oral pH, multidrug‑resistant organisms, intensive care. Citation: Sankaralingam S, Bhalekar A, Singh AK, Loha S, Kumar S, Nayak AP. A 2×1 oral care strategy (2% chlorhexidine + 1% sodium bicarbonate) significantly lowers VAP rates in mechanically ventilated CKD patients. Anaesth. pain intensive care 2025;29(9):1184-95. DOI: 10.35975/apic.v29i9.3052 Received: August 14, 2025; Revised: August 20, 2025; Accepted: August 25, 2025
Zitieren
APA
Sankaralingam, S. S., Bhalekar, A., Singh, A. K., Loha, S., Kumar, S., & Prakash, A. (2026). A 2×1 oral care strategy (2% chlorhexidine + 1% sodium bicarbonate) significantly lowers VAP rates in mechanically ventilated CKD patients. Anaesthesia, Pain & Intensive Care, 29(9), 1184-1195. https://doi.org/10.35975/apic.v29i9.3052
Vancouver
Sankaralingam SS, Bhalekar A, Singh AK, Loha S, Kumar S, Prakash A. A 2×1 oral care strategy (2% chlorhexidine + 1% sodium bicarbonate) significantly lowers VAP rates in mechanically ventilated CKD patients. Anaesthesia, Pain & Intensive Care. 2026;29(9):1184-1195. doi:10.35975/apic.v29i9.3052
BibTeX
@article{Sankaralingam2026,
author = {Sankaralingam, Subash Sankaralingam and Bhalekar, Arvind and Singh, Atul Kumar and Loha, Sandeep and Kumar, Sanjeev and Prakash, Aditya},
title = {A 2×1 oral care strategy (2% chlorhexidine + 1% sodium bicarbonate) significantly lowers VAP rates in mechanically ventilated CKD patients},
journal = {Anaesthesia, Pain & Intensive Care},
year = {2026},
volume = {29},
number = {9},
pages = {1184--1195},
doi = {10.35975/apic.v29i9.3052}
}
EUVIMED